Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening.

Journal: JAMA network open
PMID: 39235813

Abstract

IMPORTANCE: Previous research has shown good discrimination of short-term risk using an artificial intelligence (AI) risk prediction model (Mirai). However, no studies have been undertaken to evaluate whether this might translate into economic gains.

Authors

  • Harry Hill
    School of Health and Related Research, University of Sheffield, Sheffield, England.
  • Cristina Roadevin
    Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, United Kingdom.
  • Stephen Duffy
    Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
  • Olena Mandrik
    School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
  • Adam Brentnall
    Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.

Keywords

External Resources

Popular Topics
Recent Journals